Independent Director · Immix Biopharma, Inc. (IMMX)

Yekaterina Chudnovsky director compensation at Immix Biopharma: $95.5K

Fiscal year 2025 director compensation for Yekaterina Chudnovsky at Immix Biopharma, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 6, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Yekaterina Chudnovsky’s full pay file as a PDF — free

More than this page: up to 10 years of Yekaterina’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Yekaterina Chudnovsky and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Immix Biopharma Director Compensation Table · all 3 fiscal years held
In US dollars, as Immix Biopharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$42,000$0$53,496$0$95,496
FY2024$42,000—$51,726$0$93,726
FY2023$0$0$53,777$0$53,777

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immix Biopharma, Inc. DEF 14A filed April 6, 2026, accession 0001493152-26-015320, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Immix Biopharma, Inc. filed document, accession 0001493152-26-015320. Every figure is read from that document and cited to the page and table it appears in. Filed April 6, 2026.

Get the Immix Biopharma Board Governance Report

$95,496 Yekaterina Chudnovsky, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 6, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Immix Biopharma pays directors a $40,000 cash retainer and $80,000 in Options.

Committees

FY2025 · as the proxy prints them

Nominating/Governance

The rest of the Immix Biopharma board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Carey NgIndependent Director$100,996
Gabriel MorrisDirector—
Helen C. AdamsIndependent Director$125,996
Ilya RachmanChair of the Board—
Jane BuchanIndependent Director$113,996
Jason HsuIndependent Director$97,496
Magda MarquetIndependent Director$107,496
Nancy ChangIndependent Director$458,197

The full Immix Biopharma compensation record

free company brief

This page is one director within Immix Biopharma's record. The company brief lists every named executive and director, each linking to their own page.

Order IMMX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report